ZION
71
2
XEL
37
-2
SPG
48
2
BF.B
48
-2
GM
85
2
GIS
58
-2
CI
48
-4
MAR
71
3
SYF
74
5
UHS
55
3
DGX
35
2
SCHW
64
6
PRU
62
2
C
82
3
EMC
47
11
AMG
77
3
HCA
64
5
BIIB
50
4
FDX
74
3
SO
46
-5
ZION
71
2
XEL
37
-2
SPG
48
2
BF.B
48
-2
GM
85
2
GIS
58
-2
CI
48
-4
MAR
71
3
SYF
74
5
UHS
55
3
DGX
35
2
SCHW
64
6
PRU
62
2
C
82
3
EMC
47
11
AMG
77
3
HCA
64
5
BIIB
50
4
FDX
74
3
SO
46
-5
Financhill
Back

Novo Nordisk A/S Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

NVO
Novo Nordisk A/S

Last Price:
$48.11
Seasonality Move:
4.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Novo Nordisk A/S Stock Forecast

  • Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 17.8% based on the past 44 years of stock performance.
  • Novo Nordisk A/S has risen higher in 36 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.82%
  • Is Novo Nordisk A/S Stock Undervalued?
    The current Novo Nordisk A/S [NVO] share price is $48.09. The Score for NVO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk A/S Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 17.8% based on the past 44 years of stock performance.

Novo Nordisk A/S Stock Rating

Sell
24
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S overpriced?

  • Novo Nordisk A/S has risen higher in 36 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 81.82%

Novo Nordisk A/S Stock Price History

Is NVO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
93.80
52-Week Low:
43.08

Prediction Charts

Market Cap:
213.7B
Price in USD:
48.09
Volume:
10.9M
Beta:
0.48

Technical Analysis

SMA50:
50.00
SMA100:
52.53
SMA200:
60.88
52-Wk Change:
-53.51%

Stock Predictions

  • Is Novo Nordisk A/S stock public?
    Yes, Novo Nordisk A/S is a publicly traded company.
  • What is the Novo Nordisk A/S stock quote today?
    The Novo Nordisk A/S stock price is 48.09 USD today.
  • How to buy Novo Nordisk A/S stock online?
    You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 47.86 47.43 47.98 47.37
Dec-3 47.63 47.57 48.11 47.30
Dec-4 47.98 47.99 48.24 47.37
Dec-5 48.94 47.86 49.12 47.83
Dec-8 47.16 46.77 47.17 46.35
Dec-9 46.22 46.36 46.79 46.08
Dec-10 47.40 49.05 49.50 47.04
Dec-11 49.96 50.29 50.54 49.59
Dec-12 50.53 50.18 50.75 49.92
Dec-15 49.96 50.37 50.66 49.55
Dec-16 49.81 48.96 49.97 48.41
Dec-17 48.10 47.77 48.75 47.73
Dec-18 48.00 47.61 48.31 47.52
Dec-19 48.11 48.09 48.80 47.98

Novo Nordisk A/S Earnings

Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk A/S Forecast Revenue Growth

Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.

* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.